Stay updated on AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial page.

Latest updates to the AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.3.3 to the Study Record Versions list. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe record history shows the addition of Revision: v3.3.2 and the deletion of Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedA new revision entry v3.3.1 was added to the record history and the previous revision v3.2.0 was removed.SummaryDifference0.1%

- Check49 days agoChange Detected- The government funding/operating status notice at the top of the page was removed.SummaryDifference0.8%

- Check63 days agoChange DetectedA new version entry dated 2024-05-23 was added to the Record History, reflecting updates to the study's status and recruitment details.SummaryDifference0.1%

- Check92 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference13%

Stay in the know with updates to AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AB011 Injection in CLDN18.2+ Solid Tumors Clinical Trial page.